troglitazone has been researched along with African Sleeping Sickness in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fueyo González, FJ | 1 |
| Ebiloma, GU | 1 |
| Izquierdo García, C | 1 |
| Bruggeman, V | 1 |
| Sánchez Villamañán, JM | 1 |
| Donachie, A | 1 |
| Balogun, EO | 1 |
| Inaoka, DK | 1 |
| Shiba, T | 1 |
| Harada, S | 1 |
| Kita, K | 1 |
| de Koning, HP | 1 |
| Dardonville, C | 1 |
| Denninger, V | 1 |
| Figarella, K | 1 |
| Schönfeld, C | 1 |
| Brems, S | 1 |
| Busold, C | 1 |
| Lang, F | 1 |
| Hoheisel, J | 1 |
| Duszenko, M | 1 |
2 other studies available for troglitazone and African Sleeping Sickness
| Article | Year |
|---|---|
Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion.
Topics: Cell Line; Drug Discovery; Humans; Hydroxybenzoates; Membrane Potential, Mitochondrial; Mitochondria | 2017 |
Troglitazone induces differentiation in Trypanosoma brucei.
Topics: Animals; Biomarkers; Cell Differentiation; Cell Respiration; Cell Shape; Chromans; Cytochromes; Ener | 2007 |